Nicolas Sirvent
AuthID: R-00F-FD4
11
TÃTULO: Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG Full Text
AUTORES: van der Werff ten Bosch, J; Suciu, S; Thyss, A; Bertrand, Y; Norton, L; Mazingue, F; Uyttebroeck, A; Lutz, P; Robert, A; Boutard, P; Ferster, A; Plouvier, E; Maes, P; Munzer, M; Plantaz, D; Dresse, MF; Philippet, P; Sirvent, N; Waterkeyn, C; Vilmer, E; ...Mais
PUBLICAÇÃO: 2005, FONTE: LEUKEMIA, VOLUME: 19, NÚMERO: 5
AUTORES: van der Werff ten Bosch, J; Suciu, S; Thyss, A; Bertrand, Y; Norton, L; Mazingue, F; Uyttebroeck, A; Lutz, P; Robert, A; Boutard, P; Ferster, A; Plouvier, E; Maes, P; Munzer, M; Plantaz, D; Dresse, MF; Philippet, P; Sirvent, N; Waterkeyn, C; Vilmer, E; ...Mais
PUBLICAÇÃO: 2005, FONTE: LEUKEMIA, VOLUME: 19, NÚMERO: 5